BSX-Spin-out Navilyst Charts New Course
Executive Summary
Navilyst Medical, one of several properties recently spun out of Boston Scientific, has designs on growing into a large player in the venous access and fluid management industries.
You may also be interested in...
Devices Pique Private Equity's Interest
The spate of recent carve-outs from Boston Scientific has private equity and venture capital investors hungry for similar deals across the industry. But device companies don't seem to be serving much up.
Boston Scientific Shuffles and Sells in Bid to Right Ship
Boston Scientific, in a bid to raise capital and focus its efforts, is selling off lower priority businesses as well as its stakes in nearly 100 private and public companies.
Sanofi Prepares Pulmonologists As Dupixent Nears COPD Finishing Line
The French drugmaker has identified education as a key challenge ahead of its June action date for the huge-selling IL4/IL-13 inhibitor in the lung condition. An approval would make it the first biologic for the disease.